Annual Drug Patent Expirations for AXID
Axid is a drug marketed by Smithkline Beecham, Braintree, and Glaxosmithkline and, and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has two patent family members in two countries.
The generic ingredient in AXID is nizatidine. Additional details are available on the nizatidine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com